This report was recently updated on November 15 2024 with the latest and most recent
market numbers
Global Immunoprecipitation Market Size, Trends & Analysis - Forecasts to 2029 By Type (Individual Protein Immunoprecipitation, Co-Immunoprecipitation (Co-IP), Chromatin Immunoprecipitation (ChIP), RNA Immunoprecipitation (RIP), and Others), By End User (Pharmaceutical and Biotechnology Industries, Contract Research Organizations (CROs), and Academic and Research Institutes), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global immunoprecipitation market is projected to grow at a CAGR of 5.6% from 2024 to 2029.
With the increased focus on understanding the immune system and its function in health and illness, there has been a spike in research activity in immunology. Immunoprecipitation analysis techniques are critical for investigating protein-protein interactions, post-translational changes, and protein localization within cells, all of which are important in immunological research.
Immunoprecipitation applications include studying protein-protein interactions, post-translational modifications, and protein localization. They help to understand disease mechanisms, therapeutic development, and biomarker discovery. Immunoprecipitation market trends include advances in immunoprecipitation, such as chromatin immunoprecipitation (ChIP), co-immunoprecipitation assays (Co-IP), and RNA immunoprecipitation (RIP). These assays have increased their efficiency, sensitivity, and specificity. This has made immunoprecipitation methods more accessible and reliable for researchers, driving market growth.
The rising prevalence of chronic diseases such as cancer, autoimmune disorders, and infectious diseases has increased the need for research tools to help understand disease mechanisms and create targeted therapeutics. Immunoprecipitation techniques are critical for understanding disease processes, finding biomarkers, and confirming therapeutic targets, contributing to market growth. According to the World Health Organization 2023 report, noncommunicable diseases (NCDs), also known as chronic diseases, take the lives of 41 million individuals each year, which accounts for approximately 74% of all fatalities worldwide.
The growing emphasis on cancer research, driven by the escalating number of cancer cases, has underscored the importance of immunoprecipitation techniques. Immunoprecipitation in cancer research is essential as it identifies protein interactions and changes relevant to cancer. It contributes to a better knowledge of cancer progression, including medication resistance mechanisms and signaling networks. Cancer-related proteins are studied using techniques such as Co-IP and ChIP, which provide insights into cancer's molecular foundation. According to WHO, in 2022, breast cancer was responsible for around 670,000 deaths worldwide. This highlights the significant impact of breast cancer as a leading cause of mortality among women globally.
The chromatin immunoprecipitation (ChIP) segment is expected to hold the largest share of the market over the forecast period. The growth is attributed to its increasing application in epigenetics and gene regulation studies. ChIP allows for the discovery of DNA-protein interactions, histone modifications, and chromatin states, offering critical insights into gene expression control. Demand for ChIP assays is expected to rise as people become more interested in understanding the role of epigenetics in disease processes and customized therapy.
The individual protein immunoprecipitation segment is expected to be the fastest-growing segment in the market from 2024-2029. This segment dominance is analysed due to its wide-ranging applications in studying specific protein interactions, modifications, and functions. Researchers in a variety of domains, including cancer biology, immunology, and drug development, rely on individual protein immunoprecipitation techniques such as Co-IP and RIP to understand molecular pathways and find therapeutic targets.
The contract research organizations (CROs) segment is anticipated to be the fastest-growing segment in the market from 2024-2029. CROs provide specialized expertise and infrastructure for immunoprecipitation investigations, delivering cost-effective and timely results. With the increased demand for outsourced research services and the complexities of current drug development, the CRO segment is expected to grow in the immunoprecipitation market.
The academic and research institutes segment is expected to hold the largest share of the market. The segment dominance is due to the extensive use of immunoprecipitation techniques in fundamental research across various disciplines. Academic institutions and research centers conduct a wide range of investigations, including cancer research, immunology, and drug discovery, in which immunoprecipitation plays an important role in understanding molecular pathways. Furthermore, university settings frequently encourage collaboration and innovation.
North America is expected to be the largest region in the market. The primary reasons boosting the market growth in this region include advanced healthcare infrastructure and significant investments in biomedical research. Furthermore, the growing prevalence of chronic diseases increases the requirement for immunoprecipitation technologies to understand disease mechanisms better.
Asia Pacific is predicted to witness rapid growth during the forecast period. The regional market growth is due to increasing investments in healthcare infrastructure, rising prevalence of chronic diseases, and expanding research and development activities. Furthermore, the region's growing pharmaceutical and biotechnology sectors and a large population base contribute to the market expansion.
Thermo Fisher Scientific Inc., Abcam Plc, BioLegend¸ Bio-Rad Laboratories, Biologics International Corp, Creative Proteomics, GenScript Biotech Corporation, Merck KGaA, Novus Biologicals, and Takara Bio Inc., among others, are some of the key players operating in the global immunoprecipitation market.
Please note: This is not an exhaustive list of companies profiled in the report.
In April 2022, Bio-Rad Laboratories, Inc. announced the launch of a blood-based immunoassay kit designed to identify antibodies specific to the coronavirus SARS-CoV-2, the virus responsible for COVID-19. This assay, which detects total immunoglobulin (IgG, IgM, and IgA), aids in determining if an individual has been infected by the virus and has developed an immune response against it. The kit is currently undergoing clinical evaluation, demonstrating high specificity in preliminary testing.
In January 2022, BioNTech and Crescendo Biologics announced a global collaboration to develop precision immunotherapies, including mRNA-based antibodies and engineered cell therapies, for the treatment of cancer and other diseases. BioNTech will leverage Crescendo's Humabody VH platform to develop multi-specific immunotherapies against targets selected by BioNTech.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL IMMUNOPRECIPITATION MARKET, BY TYPE
4.1 Introduction
4.2 Immunoprecipitation Market: Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Individual Protein Immunoprecipitation
4.4.1 Individual Protein Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Co-Immunoprecipitation (Co-IP)
4.5.1 Co-Immunoprecipitation (Co-IP) Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Chromatin Immunoprecipitation (ChIP)
4.6.1 Chromatin Immunoprecipitation (ChIP) Market Estimates and Forecast, 2021-2029 (USD Million)
4.7 RNA Immunoprecipitation (RIP)
4.7.1 RNA Immunoprecipitation (RIP) Market Estimates and Forecast, 2021-2029 (USD Million)
4.8 Others
4.8.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL IMMUNOPRECIPITATION MARKET, BY END USER
5.1 Introduction
5.2 Immunoprecipitation Market: End User Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Pharmaceutical and Biotechnology Industries
5.4.1 Pharmaceutical and Biotechnology Industries Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Contract Research Organizations (CRO’s)
5.5.1 Contract Research Organizations (CRO’s) Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Academic and Research Institutes
5.6.1 Academic and Research Institutes Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL IMMUNOPRECIPITATION MARKET, BY REGION
6.1 Introduction
6.2 North America Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.1 By Type
6.2.2 By End User
6.2.3 By Country
6.2.3.1 U.S. Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.1.1 By Type
6.2.3.1.2 By End User
6.2.3.2 Canada Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.2.1 By Type
6.2.3.2.2 By End User
6.2.3.3 Mexico Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.3.1 By Type
6.2.3.3.2 By End User
6.3 Europe Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.1 By Type
6.3.2 By End User
6.3.3 By Country
6.3.3.1 Germany Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.1.1 By Type
6.3.3.1.2 By End User
6.3.3.2 U.K. Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.2.1 By Type
6.3.3.2.2 By End User
6.3.3.3 France Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.3.1 By Type
6.3.3.3.2 By End User
6.3.3.4 Italy Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.4.1 By Type
6.3.3.4.2 By End User
6.3.3.5 Spain Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.5.1 By Type
6.3.3.5.2 By End User
6.3.3.6 Netherlands Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Type
6.3.3.6.2 By End User
6.3.3.7 Rest of Europe Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Type
6.3.3.6.2 By End User
6.4 Asia Pacific Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.1 By Type
6.4.2 By End User
6.4.3 By Country
6.4.3.1 China Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.1.1 By Type
6.4.3.1.2 By End User
6.4.3.2 Japan Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.2.1 By Type
6.4.3.2.2 By End User
6.4.3.3 India Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.3.1 By Type
6.4.3.3.2 By End User
6.4.3.4 South Korea Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.4.1 By Type
6.4.3.4.2 By End User
6.4.3.5 Singapore Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.5.1 By Type
6.4.3.5.2 By End User
6.4.3.6 Malaysia Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Type
6.4.3.6.2 By End User
6.4.3.7 Thailand Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Type
6.4.3.6.2 By End User
6.4.3.8 Indonesia Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.7.1 By Type
6.4.3.7.2 By End User
6.4.3.9 Vietnam Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.8.1 By Type
6.4.3.8.2 By End User
6.4.3.10 Taiwan Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.10.1 By Type
6.4.3.10.2 By End User
6.4.3.11 Rest of Asia Pacific Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.11.1 By Type
6.4.3.11.2 By End User
6.5 Middle East and Africa Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.1 By Type
6.5.2 By End User
6.5.3 By Country
6.5.3.1 Saudi Arabia Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.1.1 By Type
6.5.3.1.2 By End User
6.5.3.2 U.A.E. Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.2.1 By Type
6.5.3.2.2 By End User
6.5.3.3 Israel Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.3.1 By Type
6.5.3.3.2 By End User
6.5.3.4 South Africa Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.4.1 By Type
6.5.3.4.2 By End User
6.5.3.5 Rest of Middle East and Africa Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.5.1 By Type
6.5.3.5.2 By End User
6.6 Central and South America Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.1 By Type
6.6.2 By End User
6.6.3 By Country
6.6.3.1 Brazil Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.1.1 By Type
6.6.3.1.2 By End User
6.6.3.2 Argentina Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.2.1 By Type
6.6.3.2.2 By End User
6.6.3.3 Chile Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Type
6.6.3.3.2 By End User
6.6.3.3 Rest of Central and South America Immunoprecipitation Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Type
6.6.3.3.2 By End User
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 Thermo Fisher Scientific Inc.
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 Abcam Plc
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 BioLegend
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Bio-Rad Laboratories
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 Biologics International Corp
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 Creative Proteomics
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 GenScript Biotech Corporation
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Merck KGaA
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 Novus Biologicals
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 Takara Bio Inc.
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
2 Individual Protein Immunoprecipitation Market, By Region, 2021-2029 (USD Mllion)
3 Co-Immunoprecipitation (Co-IP) Market, By Region, 2021-2029 (USD Mllion)
4 Chromatin Immunoprecipitation (ChIP) Market, By Region, 2021-2029 (USD Mllion)
5 RNA Immunoprecipitation (RIP) Market, By Region, 2021-2029 (USD Mllion)
6 Others Market, By Region, 2021-2029 (USD Mllion)
7 Global Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
8 Pharmaceutical and Biotechnology Industries Market, By Region, 2021-2029 (USD Mllion)
9 Contract Research Organizations (CRO’s) Market, By Region, 2021-2029 (USD Mllion)
10 Academic and Research Institutes Market, By Region, 2021-2029 (USD Mllion)
11 Regional Analysis, 2021-2029 (USD Mllion)
12 North America Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
13 North America Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
14 North America Immunoprecipitation Market, By COUNTRY, 2021-2029 (USD Mllion)
15 U.S. Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
16 U.S. Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
17 Canada Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
18 Canada Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
19 Mexico Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
20 Mexico Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
21 Europe Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
22 Europe Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
23 Europe Immunoprecipitation Market, By Country, 2021-2029 (USD Mllion)
24 Germany Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
25 Germany Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
26 U.K. Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
27 U.K. Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
28 France Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
29 France Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
30 Italy Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
31 Italy Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
32 Spain Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
33 Spain Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
34 Netherlands Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
35 Netherlands Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
36 Rest Of Europe Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
37 Rest Of Europe Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
38 Asia Pacific Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
39 Asia Pacific Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
40 Asia Pacific Immunoprecipitation Market, By Country, 2021-2029 (USD Mllion)
41 China Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
42 China Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
43 Japan Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
44 Japan Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
45 India Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
46 India Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
47 South Korea Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
48 South Korea Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
49 Singapore Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
50 Singapore Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
51 Thailand Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
52 Thailand Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
53 Malaysia Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
54 Malaysia Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
55 Indonesia Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
56 Indonesia Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
57 Vietnam Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
58 Vietnam Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
59 Taiwan Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
60 Taiwan Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
61 Rest of APAC Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
62 Rest of APAC Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
63 Middle East and Africa Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
64 Middle East and Africa Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
65 Middle East and Africa Immunoprecipitation Market, By Country, 2021-2029 (USD Mllion)
66 Saudi Arabia Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
67 Saudi Arabia Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
68 UAE Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
69 UAE Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
70 Israel Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
71 Israel Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
72 South Africa Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
73 South Africa Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
74 Rest Of Middle East and Africa Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
75 Rest Of Middle East and Africa Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
76 Central and South America Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
77 Central and South America Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
78 Central and South America Immunoprecipitation Market, By Country, 2021-2029 (USD Mllion)
79 Brazil Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
80 Brazil Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
81 Chile Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
82 Chile Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
83 Argentina Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
84 Argentina Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
85 Rest Of Central and South America Immunoprecipitation Market, By Type , 2021-2029 (USD Mllion)
86 Rest Of Central and South America Immunoprecipitation Market, By End User, 2021-2029 (USD Mllion)
87 THERMO FISHER SCIENTIFIC INC.: Products & Services Offering
88 Abcam Plc: Products & Services Offering
89 BioLegend: Products & Services Offering
90 Bio-Rad Laboratories : Products & Services Offering
91 Biologics International Corp: Products & Services Offering
92 CREATIVE PROTEOMICS: Products & Services Offering
93 GenScript Biotech Corporation : Products & Services Offering
94 Merck KGaA: Products & Services Offering
95 Novus Biologicals, Inc: Products & Services Offering
96 Takara Bio Inc.: Products & Services Offering
97 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Immunoprecipitation Market Overview
2 Global Immunoprecipitation Market Value From 2021-2029 (USD Mllion)
3 Global Immunoprecipitation Market Share, By Type (2023)
4 Global Immunoprecipitation Market Share, By End User (2023)
5 Global Immunoprecipitation Market, By Region (Asia Pacific Market)
6 Technological Trends In Global Immunoprecipitation Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Immunoprecipitation Market
10 Impact Of Challenges On The Global Immunoprecipitation Market
11 Porter’s Five Forces Analysis
12 Global Immunoprecipitation Market: By Type Scope Key Takeaways
13 Global Immunoprecipitation Market, By Type Segment: Revenue Growth Analysis
14 Individual Protein Immunoprecipitation Market, By Region, 2021-2029 (USD Mllion)
15 Co-Immunoprecipitation (Co-IP) Market, By Region, 2021-2029 (USD Mllion)
16 Chromatin Immunoprecipitation (ChIP) Market, By Region, 2021-2029 (USD Mllion)
17 RNA Immunoprecipitation (RIP) Market, By Region, 2021-2029 (USD Mllion)
18 Others Market, By Region, 2021-2029 (USD Mllion)
19 Global Immunoprecipitation Market: By End User Scope Key Takeaways
20 Global Immunoprecipitation Market, By End User Segment: Revenue Growth Analysis
21 Pharmaceutical and Biotechnology Industries Market, By Region, 2021-2029 (USD Mllion)
22 Contract Research Organizations (CRO’s) Market, By Region, 2021-2029 (USD Mllion)
23 Academic and Research Institutes Market, By Region, 2021-2029 (USD Mllion)
24 Regional Segment: Revenue Growth Analysis
25 Global Immunoprecipitation Market: Regional Analysis
26 North America Immunoprecipitation Market Overview
27 North America Immunoprecipitation Market, By Type
28 North America Immunoprecipitation Market, By End User
29 North America Immunoprecipitation Market, By Country
30 U.S. Immunoprecipitation Market, By Type
31 U.S. Immunoprecipitation Market, By End User
32 Canada Immunoprecipitation Market, By Type
33 Canada Immunoprecipitation Market, By End User
34 Mexico Immunoprecipitation Market, By Type
35 Mexico Immunoprecipitation Market, By End User
36 Four Quadrant Positioning Matrix
37 Company Market Share Analysis
38 Thermo Fisher Scientific Inc.: Company Snapshot
39 Thermo Fisher Scientific Inc.: SWOT Analysis
40 Thermo Fisher Scientific Inc.: Geographic Presence
41 Abcam Plc: Company Snapshot
42 Abcam Plc: SWOT Analysis
43 Abcam Plc: Geographic Presence
44 BioLegend: Company Snapshot
45 BioLegend: SWOT Analysis
46 BioLegend: Geographic Presence
47 Bio-Rad Laboratories : Company Snapshot
48 Bio-Rad Laboratories : Swot Analysis
49 Bio-Rad Laboratories : Geographic Presence
50 Biologics International Corp: Company Snapshot
51 Biologics International Corp: SWOT Analysis
52 Biologics International Corp: Geographic Presence
53 Creative Proteomics: Company Snapshot
54 Creative Proteomics: Swot Analysis
55 Creative Proteomics: Geographic Presence
56 GenScript Biotech Corporation : Company Snapshot
57 GenScript Biotech Corporation : SWOT Analysis
58 GenScript Biotech Corporation : Geographic Presence
59 Merck KGaA: Company Snapshot
60 Merck KGaA: SWOT Analysis
61 Merck KGaA: Geographic Presence
62 Novus Biologicals, Inc.: Company Snapshot
63 Novus Biologicals, Inc.: SWOT Analysis
64 Novus Biologicals, Inc.: Geographic Presence
65 Takara Bio Inc.: Company Snapshot
66 Takara Bio Inc.: SWOT Analysis
67 Takara Bio Inc.: Geographic Presence
68 Other Companies: Company Snapshot
69 Other Companies: SWOT Analysis
70 Other Companies: Geographic Presence
The Global Immunoprecipitation Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Immunoprecipitation Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
